日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Highlights in IO: next-generation CAR-T therapy for glioblastoma

免疫肿瘤学亮点:用于治疗胶质母细胞瘤的下一代CAR-T疗法

Yamaguchi, Junya; Okada, Hideho

Frontline ATRA-ATO Therapy for Acute Promyelocytic Leukemia in Japan: Results From the Prospective Multicenter FBMTG-APL2017 Trial

日本一线ATRA-ATO疗法治疗急性早幼粒细胞白血病:前瞻性多中心FBMTG-APL2017试验结果

Takase, Ken; Kamimura, Tomohiko; Kuriyama, Takuro; Tokuyama, Takahito; Henzan, Hideho; Kikushige, Yoshikane; Choi, Ilseung; Imamura, Yutaka; Mori, Akio; Ohya, Shuki; Kawano, Noriaki; Yonemoto, Koji; Harada, Mine; Akashi, Koichi; Miyamoto, Toshihiro

Focused ultrasound-enhanced cell therapy for brain tumors: Summary of roundtable discussions

聚焦超声增强细胞疗法治疗脑肿瘤:圆桌讨论总结

Padilla, Frederic; Arvanitis, Costas; Bollard, Catherine M; Gallus, Marco; De Groot, John; Klein, Robyn S; Ransohoff, Richard M; Sonabend, Adam M; Okada, Hideho

Spike-in probe-enhanced single-cell RNA-seq reveals post-infusion transcriptomic remodeling of "prime-and-kill" synNotch-CAR-T cells

利用添加探针增强的单细胞RNA测序揭示了“启动和杀伤”synNotch-CAR-T细胞输注后的转录组重塑

Nejo, Takahide; Watchmaker, Payal B; Simic, Milos S; Yamamichi, Akane; Lakshmanachetty, Senthilnath; Zhao, Aishi; Lu, Jianwen; Gallus, Marco; Benway, Heather L; Zhu, Robert; Almeida, Ricardo; Lim, Wendell A; Okada, Hideho

Tumour-wide RNA splicing aberrations generate actionable public neoantigens

肿瘤范围内的RNA剪接异常会产生可靶向的公共新抗原

Darwin W Kwok ,Nicholas O Stevers ,Iñaki Etxeberria ,Takahide Nejo ,Maggie Colton Cove ,Lee H Chen ,Jangham Jung ,Kaori Okada ,Senthilnath Lakshmanachetty ,Marco Gallus ,Abhilash Barpanda ,Chibo Hong ,Gary K L Chan ,Jerry Liu ,Samuel H Wu ,Emilio Ramos ,Akane Yamamichi ,Payal B Watchmaker ,Hirokazu Ogino ,Atsuro Saijo ,Aidan Du ,Nadia R Grishanina ,James Woo ,Aaron Diaz ,Shawn L Hervey-Jumper ,Susan M Chang ,Joanna J Phillips ,Arun P Wiita ,Christopher A Klebanoff ,Joseph F Costello ,Hideho Okada

FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastoma

FcRn沉默IL-12Fc可预防局部IL-12治疗的毒性并延长实验性胶质母细胞瘤的生存期。

Michal Beffinger # ,Linda Schellhammer # ,Betül Taskoparan # ,Sereina Deplazes ,Ulisse Salazar ,Nazanin Tatari ,Frauke Seehusen ,Leopold von Balthazar ,Carl Philipp Zinner ,Sabine Spath ,Tala Shekarian ,Marie-Françoise Ritz ,Marta McDaid ,Pascal Egloff ,Iwan Zimmermann ,Hideho Okada ,E Sally Ward ,Jack Rohrer ,Markus A Seeger ,Thorsten Buch ,Gregor Hutter ,Johannes Vom Berg

The T-cell receptor repertoire: A window into pediatric brain tumor immunity

T细胞受体库:了解儿童脑肿瘤免疫的窗口

Nejo, Takahide; Prins, Robert M; Okada, Hideho

Response Assessment in Neuro-Oncology (RANO) 2009-2025: Broad scope and implementation-A progress report

神经肿瘤学反应评估(RANO)2009-2025:广泛范围和实施——进展报告

van den Bent, Martin J; Vogelbaum, Michael A; Cloughesy, Tim; Galldiks, Norbert; Albert, Nathalie L; Tonn, Joerg-Christian; Avila, Edward; Fangusaro, Jason; Mirsky, David; Sahgal, Arjun; Soffietti, Ricardo; Karschnia, Philipp; Mehta, Minesh; Kim, Michelle M; Boele, Florien; Huse, Jason T; Nayak, Lakshmi; Lim-Fat, Mary Jane; le Rhun, Emilie; Desjardins, Annick; Lee, Eudocia Q; Chukwueke, Ugonma; Koekkoek, Johan A F; Mendoza, Tito; Loughan, Ashlee R; Budhu, Joshua A; Bakas, Spyridon; Huang, Raymond Y; Villanueva-Meyer, Javier E; Leone, Jose Pablo; Okada, Hideho; Reardon, David A; Bi, Wenya L; Wen, Patrick Y; Chang, Susan M

Chimeric antigen receptor T-cell therapy in patients with malignant glioma-From neuroimmunology to clinical trial design considerations

嵌合抗原受体T细胞疗法在恶性胶质瘤患者中的应用——从神经免疫学到临床试验设计考量

Gallus, Marco; Young, Jacob S; Cook Quackenbush, Sarah; Khasraw, Mustafa; de Groot, John; Okada, Hideho

IMMU-49. Outcomes of SRS and Ipilimumab/Nivolumab Among Patients with Melanoma Brain Metastases

IMMU-49. 立体定向放射外科手术联合伊匹木单抗/纳武单抗治疗黑色素瘤脑转移患者的疗效

Hu, Qi-Long; Liang, Steven H; Du, Rebecca; Arrieta, Victor; Benotbatme, Jasim K; Govind, Sachin; Habashy, Karl J; Najem, Hinda; Vazquez-Cervantes, Gustavo; Wang, Si; Katz, Joshua; Wan, Hanxiao; Murphy, Alina; Jamshidi, Pouya; Horbinski, Craig; Sonabend, Adam M; Heimberger, Amy B; Chandler, James P; Wolinsky, Jean-Paul; Lee-Chang, Catalina; Raskin, Scott; Yang, Changlin; Lin, Tong; Yearley, Jennifer; Blumenschein, Wendy; Pillay-Smiley, Natasha; Lenzen, Alicia; Partap, Sonia; Fangusaro, Jason; Gururangan, Sridharan; Onar-Thomas, Arzu; Fouladi, Maryam; Dunkel, Ira; Mitchell, Duane; Hwang, Eugene; Sloan, Anthony; Bukenya, George; Aggarwal, Anu; Lee, Juyeun; Rosaff, Daniel; Alban, Tyler; Juric, Ivan; Silver, Daniel; Tack, Liza; Navadgi, Tanvi; Reitz, Natalie; Tannish, Gavin; Yuan, Xueer; Coker, Jesse; Scalise, Alliefair; Rajasekar, Bhairavi; Vincenti, Alex; Mulkearns-Hubert, Erin; Horbinski, Craig; Sloan, Andrew; Hubert, Christopher; Luo, Jingqin; Rubin, Joshua; Stavrou, Evi; Lohoff, Falk; Nieman, Marvin; Sangwan, Naseer; Chan, Timothy; Khorana, Alok; Dhawan, Andrew; Cameron, Scott; Lathia, Justin; Gallus, Marco; Yamamichi, Akane; Arrieta, Victor Andres; Nejo, Takahide; Phung, Lan; Saijo, Atsuro; Chuntova, Pavlina; Lu, Jianwen; Phyu, Su; Zhao, Aishi; Okada, Kaori; Watchmaker, Payal; Haegelin, Jeffrey; Lakshmanachetty, Senthilnath; Habashy, Karl; Canney, Michael; Sonabend, Adam M; Okada, Hideho; Linkowski, Lauren; Messing, Ian; Riina, Matthew; Berger, Melanie; Fu, Johnathan; Wang, Xingmei; Hubbeling, Harper; Lustig, Robert A; Dorsey, Jay F; Kurtz, Goldie; Nagda, Suneel; Flowers, Ahron; Lee, John Y K; Amankulor, Nduka; Jackson, Christina; Mohan, Suyash; Lukens, J Nicholas; Amaravadi, Ravi K; Haung, Alexander C; Mitchell, Tara; Alonso-Basanta, Michelle; Lebow, Emily